European Journal of Drug Metabolism and Pharmacokinetics
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.3 | Q3 | 36.8% | 0.632 | Q2 | 69.4% |
| 2024 | 2.4 | Q3 | 45.0% | 0.694 | Q2 | 73.3% |
| 2023 | 1.9 | Q3 | 36.8% | 0.462 | Q3 | 62.3% |
| 2022 | 1.9 | Q4 | 29.9% | 0.524 | Q2 | 67.7% |
| 2021 | 2.6 | Q3 | 45.3% | 0.530 | Q2 | 69.0% |
| 2020 | — | — | 0.573 | Q2 | 70.4% | |
| 2019 | — | — | 0.517 | Q3 | 68.5% | |
| 2018 | — | — | 0.488 | Q3 | 64.6% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0378-7966
ISSN
2107-0180
country
CHcoverage
1976-2026